meta|evidence COVID-19
  • Living systematic review and meta-analysis
  • adjuvant therapies
  • anti-inflammatoty and immuno-therapy
  • antiandrogenic
  • antiviral and associated therapy
  • control
  • Drugs for acid related disorders
  • miscellaneous
  • 2-deoxy-D-glucose (2-DG)
  • acetylcysteine
  • alpha lipoic acid
  • anti-CK2
  • Aspirin
  • aviptadil
  • BLD-2660 (calpain inhibitor)
  • calcium channel blocker
  • camostat mesilate
  • Cannabidiol
  • continuous positive airway pressure (CPAP)
  • cytokine adsorption
  • diammonium glycyrrhizinate
  • dipyridamol
  • dornase alfa
  • expectorants and mucolytics
  • honey
  • kinin-kallikrein inhibitors
  • melatonin
  • mouthrise and gargling agents
  • mouthrinses
  • N-Acetylcysteine
  • nasal spray
  • nasal spray containing Iota-Carrageenan
  • natural killer (NK) cells
  • nicotin
  • nigella sativa oil
  • nitric oxide (gas Inhalation or releasing solution)
  • omega-3 Polyunsaturated Fatty Acids
  • ozonated autohemotherapy
  • plasma exchange
  • povidone-iodine
  • previfenon (EGCG)
  • prostacyclin
  • PUL-042 inhalation solution
  • pyridostigmine
  • radiotherapy
  • sabizabulin
  • sildenafil
  • triiodothyronine (T3)
  • Oral antidiabetic drugs
  • Renin-angiotensin-system-acting agents
  • vaccines
  • Vitamins
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 (hospitalized or not)
  • COVID-19 prophylaxis (children)
  • COVID-19 prophylaxis (excluding children)
  • infections other than COVID-19
  • Long COVID-19
  • preventing respiratory virus transmission
  • secondary prevention